Native Antigen Company launches new Zika immunoassays with unprecedented specificity and sensitivity

The Native Antigen Company has launched a series of ground-breaking immunoassays for Zika virus offering researchers in academia public health and drug discovery the capability to work with unprecedented levels of specificity and sensitivity

from rapidmicrobiology https://ift.tt/2Sqd55p